Calr plus Myelofibrosis/BCR-ABL Chronic Myeloid Leukemia Overlap Syndrome Treated with Asciminib

被引：0
|
作者：
Saal, Talia M. [1 ]
Pellegrino, Christine [2 ]
Ahmed, Tauseef [2 ]
Seiter, Karen [3 ]
Liu, Delong [2 ]
Steinberg, Amir [2 ]
机构：
[1] New York Med Coll, Valhalla, NY 10595 USA
[2] Westchester Med Ctr, Valhalla, NY USA
[3] Westchester Med Ctr, Larchmont, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184820
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene
    Joana Maria Saraiva Diamond
    António Medina de Almeida
    Hélio José Loureço Miguéns Rodrigues Belo
    Manuela Paula Guerra Pinheiro Gameiro da Costa
    José Manuel Valente Sequeira Cabeçadas
    Manuel Maria de Sousa Ferreira Abecasis
    Annals of Hematology, 2016, 95 : 2101 - 2104
  • [22] BCR-ABL BREAKPOINT AND PROGNOSIS IN CHRONIC MYELOID-LEUKEMIA
    BACCARANI, M
    SAGLIO, G
    ZACCARIA, A
    TURA, S
    BLOOD, 1992, 79 (09) : 2499 - 2500
  • [23] Prognostic significance of BCR-ABL rearrangement in chronic myeloid leukemia
    Colleoni, GWB
    Costa, FF
    Grignolli, CRE
    Silva, RS
    Chauffaille, MLLF
    Kerbauy, J
    Saad, STO
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1996, 29 (10) : 1307 - 1310
  • [24] Systematic analysis of BCR-ABL interactome in chronic myeloid leukemia
    Gregor, T.
    Rynes, J.
    Foldynova-Trantirkova, S.
    Mayer, J.
    Krejci, P.
    Trantirek, L.
    FEBS JOURNAL, 2017, 284 : 286 - 286
  • [25] CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene
    Saraiva Diamond, Joana Maria
    de Almeida, Antonio Medina
    Miguens Rodrigues Belo, Helio Jose Loureco
    Pinheiro Gameiro da Costa, Manuela Paula Guerra
    Valente Sequeira Cabecadas, Jose Manuel
    de Sousa Ferreira Abecasis, Manuel Maria
    ANNALS OF HEMATOLOGY, 2016, 95 (12) : 2101 - 2104
  • [26] Clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate
    Nicolini, Franck
    HEMATOLOGIE, 2006, 12 (06): : 373 - 374
  • [27] BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival
    Barbosa Pagnano, Katia Borgia
    Bendit, Israel
    Boquimpani, Carla
    De Souza, Carmino Antonio
    Miranda, Eliana C. M.
    Zalcberg, Ilana
    Larripa, Irene
    Nardinelli, Luciana
    Silveira, Rosana Antunes
    Fogliatto, Laura
    Spector, Nelson
    Funke, Vaneuza
    Pasquini, Ricardo
    Hungria, Vania
    Chiattone, Carlos Sergio
    Clementino, Nelma
    Conchon, Monika
    Beatriz Moiraghi, Elena
    Lopez, Jose Luis
    Pavlovsky, Carolina
    Pavlovsky, Miguel A.
    Cervera, Eduardo E.
    Antonio Meillon, Luis
    Simoes, Belinda
    Hamerschlak, Nelson
    Magarinos Bozzano, Alicia Helena
    Mayta, Ernesto
    Cortes, Jorge
    Bengio, Raquel M.
    CANCER INVESTIGATION, 2015, 33 (09) : 451 - 458
  • [28] The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia
    El-Tanani, Mohamed
    Nsairat, Hamdi
    Matalka, Ismail I.
    Lee, Yin Fai
    Rizzo, Manfredi
    Aljabali, Alaa A.
    Mishra, Vijay
    Mishra, Yachana
    Hromic-Jahjefendic, Altijana
    Tambuwala, Murtaza M.
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
  • [29] The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemia
    Wang, LH
    Knight, K
    Lucas, C
    Clark, RE
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (02): : 235 - 239
  • [30] Chronic myeloid leukemia with p210 BCR-ABL and monocytosis
    Dass, Jasmita
    Jain, Sonal
    Tyagi, Seema
    Sazawal, Sudha
    LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1380 - 1381
12345